The Following publications have emanated from our HIV Prophylaxis Research:

  • Enzyme Responsive Vaginal Microbicide Gels Containing Maraviroc and Tenofovir Microspheres Designed for Acid Phosphatase-Triggered Release for Pre-Exposure Prophylaxis of HIV-1: A Comparative Analysis of a Bigel and Thermosensitive Gel. Gels 2022, 8, 15.
  • Mucoadhesive Microspheres of Maraviroc and Tenofovir Designed for Pre-Exposure Prophylaxis of HIV-1: An in vitro Assessment of the Effect on Vaginal Lactic Acid Bacteria Microflora. HIV/ AIDS – Research and Palliative Care. 13:399-413.
  • Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis. Future Journal of Pharmaceutical Sciences 6, 81 (2020).
  • Development of trigger sensitive hyaluronic acid/palm oil-based organogel for in vitro release of HIV/AIDS microbicides using artificial neural networks. Future J Pharm Sci 6, 1